See the DrugPatentWatch profile for Xiidra
Xiidra (lifitegrast) pricing can vary depending on factors such as insurance coverage, pharmacy, and whether a discount program is utilized. The average retail price for a 30-day supply of Xiidra is approximately $550 to $600 [1].
How much does Xiidra cost with insurance?
Insurance coverage for Xiidra often involves a copay. The actual cost to a patient with insurance can range from $25 to $150 per month, depending on the specific insurance plan [1]. Patients are advised to contact their insurance provider for precise cost details.
Are there ways to get Xiidra at a lower cost?
Yes, there are programs that can help reduce the cost of Xiidra. The manufacturer offers a savings program for eligible commercially insured patients. This program can lower the monthly out-of-pocket cost to as little as $0 [1]. For those without insurance or with high deductibles, other discount options may be available through pharmacies or third-party discount providers.
When does the Xiidra patent expire?
The patent protection for Xiidra has a complex timeline. While initial patents were granted, further patent applications and associated exclusivity periods can extend market protection. Information on specific patent expiry dates and potential challenges can be found on resources like DrugPatentWatch.com [2].
What is the mechanism of action for Xiidra?
Xiidra is a prescription eye drop that works by blocking the T-cell surface protein, LFA-1. This interaction prevents LFA-1 from binding with its cognate ligand, ICAM-1. ICAM-1 is thought to play a role in chronic inflammation that can be associated with dry eye disease. By blocking this interaction, Xiidra helps to reduce inflammation [3].
How does Xiidra compare to other dry eye treatments?
Xiidra is a prescription medication used to treat the signs and symptoms of dry eye disease. Other treatments for dry eye include artificial tears, which provide lubrication, and other prescription medications that may target different aspects of the inflammatory pathway. The choice of treatment depends on the severity and underlying cause of dry eye [3].
Sources:
[1] https://www.myeyedrops.com/xiidra-cost/
[2] https://drugpatentwatch.com/
[3] https://www.xiidra.com/